Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WDR75 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
mRNA | ITGBL1 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
mRNA | EZH2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | TYMS | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | RUVBL1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
mRNA | LTBR | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
mRNA | SFPQ | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | GEMIN4 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | WWC1 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
mRNA | HNRNPA1L2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |